Following the acquisition of the CE mark, the device will be introduced across 14 cardiac surgery centers in Europe in January 2027.
A new journal section challenges biomedical engineers to prove their devices deliver real clinical outcomes for patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results